From Traditional Ethnopharmacology to Modern Natural Drug Discovery: A Methodology Discussion and Specific Examples
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Ethnopharmacology, through the description of the beneficial effects of plants, has provided an early framework for the therapeutic use of natural compounds. Natural products, either in their native form or after crude extraction of their active ingredients, have long been used by different populations and explored as invaluable sources for drug design. The transition from traditional ethnopharmacology to drug discovery has followed a straightforward path, assisted by the evolution of isolation and characterization methods, the increase in computational power, and the development of specific chemoinformatic methods. The deriving extensive exploitation of the natural product chemical space has led to the discovery of novel compounds with pharmaceutical properties, although this was not followed by an analogous increase in novel drugs. In this work, we discuss the evolution of ideas and methods, from traditional ethnopharmacology to in silico drug discovery, applied to natural products. We point out that, in the past, the starting point was the plant itself, identified by sustained ethnopharmacological research, with the active compound deriving after extensive analysis and testing. In contrast, in recent years, the active substance has been pinpointed by computational methods (in silico docking and molecular dynamics, network pharmacology), followed by the identification of the plant(s) containing the active ingredient, identified by existing or putative ethnopharmacological information. We further stress the potential pitfalls of recent in silico methods and discuss the absolute need for in vitro and in vivo validation as an absolute requirement. Finally, we present our contribution to natural products’ drug discovery by discussing specific examples, applying the whole continuum of this rapidly evolving field. In detail, we report the isolation of novel antiviral compounds, based on natural products active against influenza and SARS-CoV-2 and novel substances active on a specific GPCR, OXER1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Daina, A., Michielin, O., & Zoete, V. (2017) · Scientific Reports · doi:10.1038/srep42717 · Cited by 18,367
Plant Products as Antimicrobial Agents
Cowan, M. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.564 · Cited by 9,043
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Natural products as sources of new drugs over the period 1981–2002
Newman, D. J., Cragg, G. M., & Snader, K. M. (2003) · Journal of Natural Products · doi:10.1021/np030096l · Cited by 3,082
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981 · cited 5×
“About 114,000 extracts from an estimated 35,000 plant samples (representing 12,000–13,000 species), collected mostly from temperate regions of the world, had been screened against a number of tumor systems between 1960 and 1982 [27,86,87].”
BackgroundInfluentialWhy 90% of clinical drug development fails and how to improve it?
Sun, D., Gao, W., Hu, H., & Zhou, S. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.002 · Cited by 1,763
From waste products to ecochemicals: Fifty years research of plant secondary metabolism
Hartmann, T. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.09.017 · Cited by 798 · cited 1×
“Plants synthesize an immensely rich diversity of specialized secondary metabolites comprising an enormous number of active or complementary compounds [18,19].”
Background
Research works printed but not linked: 122
- Halberstein, 2005, Medicinal plants: Historical and cross-cultural usage patterns, Ann. Epidemiol., 15, 686, 10.1016/j.annepidem.2005.02.004 · DOI · Paper page
- Hardy, 2021, Paleomedicine and the Evolutionary Context of Medicinal Plant Use, Rev. Bras. Farmacogn., 31, 1, 10.1007/s43450-020-00107-4 · DOI
- Malik, 2011, Production of the anticancer drug taxol in Taxus baccata suspension cultures: A review, Broc. Biochem., 46, 23
- Gallego-Jara, J., Lozano-Terol, G., Sola-Martinez, R.A., Canovas-Diaz, M., and de Diego Puente, T. (2020). A Compressive Review about Taxol((R)): History and Future Challenges. Molecules, 25. · DOI · Paper page
- Rose, 1992, Taxol: A review of its preclinical in vivo antitumor activity, Anticancer Drugs, 3, 311, 10.1097/00001813-199208000-00001 · doi:10.1097/00001813-199208000-00001
- Brade, 1981, Critical Review of Pharmacology, Toxicology, Pharmacokinetics of Vincristine, Vindesine, Vinblastine, International Vinca Alkaloid Symposium—Vindesine, Volume 6, 95, 10.1159/000428623 · doi:10.1159/000428623
- Nelson, 1982, The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer, Med. Pediatr. Oncol., 10, 115, 10.1002/mpo.2950100202 · DOI
- Achan, 2011, Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria, Malar J., 10, 144, 10.1186/1475-2875-10-144 · DOI · Paper page
- Liles, 2016, Diversity and severity of adverse reactions to quinine: A systematic review, Am. J. Hematol., 91, 461, 10.1002/ajh.24314 · DOI
- Dai, 2017, The pharmacological activities and mechanisms of artemisinin and its derivatives: A systematic review, Med. Chem. Res., 26, 867, 10.1007/s00044-016-1778-5 · DOI
- Fabricant, 2001, The value of plants used in traditional medicine for drug discovery, Environ. Health Perspect., 109, 69
- Dias, 2012, A historical overview of natural products in drug discovery, Metabolites, 2, 303, 10.3390/metabo2020303 · DOI · Paper page
- Najmi, A., Javed, S.A., Al Bratty, M., and Alhazmi, H.A. (2022). Modern Approaches in the Discovery and Development of Plant-Based Natural Products and Their Analogues as Potential Therapeutic Agents. Molecules, 27. · DOI · Paper page
- Fattore, M., and Bruggemann, R. (2017). Analyzing Ethnopharmacological Data Matrices on Traditional Uses of Medicinal Plants with the Contribution of Partial Order Techniques. Partial Order Concepts in Applied Sciences, Springer. · doi:10.1007/978-3-319-45421-4
- Karali, 2016, T cell regulation by Phlomis lanata protein extracts in mice, Pharm. Biol., 54, 207, 10.3109/13880209.2015.1027780 · doi:10.3109/13880209.2015.1027780
- Murugan, N.A., Podobas, A., Gadioli, D., Vitali, E., Palermo, G., and Markidis, S. (2022). A Review on Parallel Virtual Screening Softwares for High-Performance Computers. Pharmaceuticals, 15. · DOI
- Zaman, 2021, Predicting potential medicinal plants with phylogenetic topology: Inspiration from the research of traditional Chinese medicine, J. Ethnopharmacol., 281, 114515, 10.1016/j.jep.2021.114515 · DOI
- Zaman, 2022, Phylogenetic exploration of traditional chinese medicinal plants: A case study of Lamiaceae, Pak. J. Bot., 54, 1033, 10.30848/PJB2022-3(19) · doi:10.30848/pjb2022-3(19
- Martin, 1995, Accomplishments and challenges in integrating software for computer-aided ligand design in drug discovery, Persp. Drug Discov. Des., 3, 139, 10.1007/BF02174471 · DOI
- Boezio, 2017, Network-based Approaches in Pharmacology, Mol. Inform., 36, 1700048, 10.1002/minf.201700048 · DOI · Paper page
- Soejarto, 2005, Ethnobotany/ethnopharmacology and mass bioprospecting: Issues on intellectual property and benefit-sharing, J. Ethnopharmacol., 100, 15, 10.1016/j.jep.2005.05.031 · DOI
- Mukherjee, 2010, Ethnopharmacology and integrative medicine—Let the history tell the future, J. Ayurveda Integr. Med., 1, 100, 10.4103/0975-9476.65077 · DOI
- Heinrich, 2001, Ethnopharmacology in drug discovery: An analysis of its role and potential contribution, J. Pharm. Pharmacol., 53, 425, 10.1211/0022357011775712 · DOI · Paper page
- 2015, Ethnobotanical survey of medicinal plants in Bozyazi district of Mersin, Turkey, J. Ethnopharmacol., 173, 105, 10.1016/j.jep.2015.07.009 · DOI
- Zhao, 2021, Prevention and treatment of COVID-19 using Traditional Chinese Medicine: A review, Phytomedicine, 85, 153308, 10.1016/j.phymed.2020.153308 · DOI · Paper page
- Heinrich, M., and Jäger, A. (2015). Medicinal Plant Research: A Reflection on Translational Tasks. Ethnopharmacology, Karger. · DOI
- Thomford, N.E., Senthebane, D.A., Rowe, A., Munro, D., Seele, P., Maroyi, A., and Dzobo, K. (2018). Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery. Int. J. Mol. Sci., 19. · DOI · Paper page
- Pirintsos, 2020, The Therapeutic Potential of the Essential Oil of Thymbra capitata (L.) Cav., Origanum dictamnus L. and Salvia fruticosa Mill. and a Case of Plant-Based Pharmaceutical Development, Front. Pharmacol., 11, 522213, 10.3389/fphar.2020.522213 · DOI
- Hanlidou, 2004, The herbal market of Thessaloniki (N Greece) and its relation to the ethnobotanical tradition, J. Ethnopharmacol., 91, 281, 10.1016/j.jep.2004.01.007 · doi:10.1016/j.jep.2004.01.007
- 2010, The relevance of traditional knowledge systems for ethnopharmacological research: Theoretical and methodological contributions, J. Ethnobiol. Ethnomed., 6, 32, 10.1186/1746-4269-6-32 · DOI
- Heinrich, 2010, Ethnopharmacology in the 21st century—Grand challenges, Front. Pharmacol., 1, 8, 10.3389/fphar.2010.00008 · DOI
- Laina, 2017, Partial ordering of undesirable effects reported for traditionally used medicinal herbal substances, Toxicol. Environ. Chem., 99, 1230
- Brüggemann, R., and Patil, G. (2011). Ranking and Prioritization for Multi-Indicator Systems: Introduction to Partial Order Applications, Springer. · doi:10.1007/978-1-4419-8477-7
- Bariotakis, 2019, From wild harvest towards precision agriculture: Use of Ecological Niche Modelling to direct potential cultivation of wild medicinal plants in Crete, Sci. Total Environ., 694, 133681, 10.1016/j.scitotenv.2019.133681 · DOI
- Yeung, 2020, The ethnopharmacological literature: An analysis of the scientific landscape, J. Ethnopharmacol., 250, 112414, 10.1016/j.jep.2019.112414 · DOI
- Alzweiri, 2011, Ethnopharmacological survey of medicinal herbs in Jordan, the Northern Badia region, J. Ethnopharmacol., 137, 27, 10.1016/j.jep.2011.02.007 · DOI · Paper page
- Karousou, 2011, The herbal market of Cyprus: Traditional links and cultural exchanges, J. Ethnopharmacol., 133, 191, 10.1016/j.jep.2010.09.034 · doi:10.1016/j.jep.2010.09.034
- 2009, Ethnopharmacological survey of wild medicinal plants in Showbak, Jordan, J. Ethnopharmacol., 123, 45, 10.1016/j.jep.2009.02.031 · DOI · Paper page
- Hudaib, 2008, Ethnopharmacological survey of medicinal plants in Jordan, Mujib Nature Reserve and surrounding area, J. Ethnopharmacol., 120, 63, 10.1016/j.jep.2008.07.031 · doi:10.1016/j.jep.2008.07.031
- Lardos, 2006, The botanical materia medica of the Iatrosophikon—A collection of prescriptions from a monastery in Cyprus, J. Ethnopharmacol., 104, 387, 10.1016/j.jep.2005.12.035 · doi:10.1016/j.jep.2005.12.035
- Said, 2002, Ethnopharmacological survey of medicinal herbs in Israel, the Golan Heights and the West Bank region, J. Ethnopharmacol., 83, 251, 10.1016/S0378-8741(02)00253-2 · DOI · Paper page
- Lev, 2000, Ethnopharmacological survey of traditional drugs sold in Israel at the end of the 20th century, J. Ethnopharmacol., 72, 191, 10.1016/S0378-8741(00)00230-0 · doi:10.1016/s0378-8741(00)00230-0
- Yaghmour, 1998, Antimicrobial activity of 20 plants used in folkloric medicine in the Palestinian area, J. Ethnopharmacol., 60, 265, 10.1016/S0378-8741(97)00153-0 · DOI · Paper page
- Suarez, 1997, Medicinal plants used in the Barros Area, Badajoz Province (Spain), J. Ethnopharmacol., 55, 81, 10.1016/S0378-8741(96)01491-2 · doi:10.1016/s0378-8741(96)01491-2
- Honda, 1996, Traditional medicine in Turkey VI. Folk medicine in West Anatolia: Afyon, Kütahya, Denizli, Muğla, Aydin provinces, J. Ethnopharmacol., 53, 75
- 1995, A Survey of Plants Used in Jordanian Traditional Medicine, Int. J. Pharmacogn., 33, 317, 10.3109/13880209509065385 · DOI · Paper page
- Dafni, 1984, Ethnobotanical survey of medicinal plants in northern Israel, J. Ethnopharmacol., 10, 295, 10.1016/0378-8741(84)90017-5 · doi:10.1016/0378-8741(84)90017-5
- Qnais, 2007, Antidiarrheal Activity of the Aqueous Extract of Punica granatum. (Pomegranate) Peels, Pharm. Biol., 45, 715, 10.1080/13880200701575304 · DOI
- Mroueh, 2011, Pharmacological evaluation of aqueous extract of Althaea officinalis flower grown in Lebanon, Pharm. Biol., 49, 327, 10.3109/13880209.2010.516754 · doi:10.3109/13880209.2010.516754
- Hsu, 2007, Antioxidant activity of extract from Polygonum cuspidatum, Biol. Res.Res., 40, 13
- Hsu, 2006, Antioxidant activity of extract from Polygonum aviculare L., Biol. Res., 39, 281, 10.4067/S0716-97602006000200010 · DOI
- Perianayagam, 2006, Anti-inflammatory activity of Trichodesma indicum root extract in experimental animals, J. Ethnopharmacol., 104, 410, 10.1016/j.jep.2005.08.077 · doi:10.1016/j.jep.2005.08.077
- Garrido, 2004, In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (VIMANG), Pharmacol. Res., 50, 143, 10.1016/j.phrs.2003.12.003 · DOI · Paper page
- Rajeshkumar, 2002, Antitumour and anticarcinogenic activity of Phyllanthus amarus extract, J. Ethnopharmacol., 81, 17, 10.1016/S0378-8741(01)00419-6 · DOI · Paper page
- Olajide, 2000, Studies on the anti-inflammatory and related pharmacological properties of the aqueous extract of Bridelia ferruginea stem bark, J. Ethnopharmacol., 71, 153, 10.1016/S0378-8741(99)00201-9 · DOI
- Bhakta, 1998, Studies on Antitussive Activity of Cassia fistula (Leguminosae) Leaf Extract, Pharm. Biol., 36, 140, 10.1076/phbi.36.2.140.4598 · doi:10.1076/phbi.36.2.140.4598
- Bartoszewski, 2019, Comprehensive review of antimicrobial activities of plant flavonoids, Phytochem. Rev., 18, 241, 10.1007/s11101-018-9591-z · DOI · Paper page
- Adamski, Z., Blythe, L.L., Milella, L., and Bufo, S.A. (2020). Biological Activities of Alkaloids: From Toxicology to Pharmacology. Toxins, 12. · doi:10.3390/toxins12040210
- Pizzi, 2021, Tannins medical / pharmacological and related applications: A critical review, Sust. Chem. Pharm., 22, 100481
- Metwaly, A.M., Lianlian, Z., Luqi, H., and Deqiang, D. (2019). Black Ginseng and Its Saponins: Preparation, Phytochemistry and Pharmacological Effects. Molecules, 24. · DOI
- Yang, 2020, Advances in Pharmacological Activities of Terpenoids, Nat. Prod. Commun., 15, 1934578X20903555
- Hinkson, 2020, Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery, Front. Pharmacol., 11, 770, 10.3389/fphar.2020.00770 · DOI · Paper page
- Lionis, 1998, Antioxidant effects of herbs in Crete, Lancet, 352, 1987, 10.1016/S0140-6736(05)61333-5 · doi:10.1016/s0140-6736(05)61333-5
- Castree, 2003, Bioprospecting: From theory to practice (and back again), Trans. Inst. Brit. Geograph., 28, 35, 10.1111/1475-5661.00076 · DOI
- Buenz, 2004, Techniques: Bioprospecting historical herbal texts by hunting for new leads in old tomes, Trends Pharmacol. Sci., 25, 494, 10.1016/j.tips.2004.07.003 · DOI
- Roersch, 2010, Piper umbellatum L.: A comparative cross-cultural analysis of its medicinal uses and an ethnopharmacological evaluation, J. Ethnopharmacol., 131, 522, 10.1016/j.jep.2010.07.045 · DOI
- Hao, 2020, Pharmaceutical resource discovery from traditional medicinal plants: Pharmacophylogeny and pharmacophylogenomics, Chin. Herb. Med., 12, 104
- Zhu, 2011, Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting, Proc. Natl. Acad. Sci. USA, 108, 12943, 10.1073/pnas.1107336108 · DOI · Paper page
- Williamson, 2011, Cross-cultural comparison of three medicinal floras and implications for bioprospecting strategies, J. Ethnopharmacol., 135, 476, 10.1016/j.jep.2011.03.044 · DOI
- Savolainen, 2012, Phylogenies reveal predictive power of traditional medicine in bioprospecting, Proc. Natl. Acad. Sci. USA, 109, 15835, 10.1073/pnas.1202242109 · DOI · Paper page
- Kalyvianaki, 2020, Toxicity evaluation of an essential oil mixture from the Cretan herbs thyme, Greek sage and Cretan dittany, NPJ Sci. Food, 4, 20, 10.1038/s41538-020-00080-1 · DOI
- Tseliou, 2019, Antiviral effect of an essential oil combination derived from three aromatic plants (Coridothymus capitatus (L.) Rchb. f., Origanum dictamnus L. and Salvia fruticosa Mill.) against viruses causing infections of the upper respiratory tract, J. Herb. Med., 17–18, 100288, 10.1016/j.hermed.2019.100288 · doi:10.1016/j.hermed.2019.100288
- Duijker, 2015, Reporting effectiveness of an extract of three traditional Cretan herbs on upper respiratory tract infection: Results from a double-blind randomized controlled trial, J. Ethnopharmacol., 163, 157, 10.1016/j.jep.2015.01.030 · DOI
- Anastasaki, M., Bertsias, A., Pirintsos, S.A., Castanas, E., and Lionis, C. (2017). Post-market outcome of an extract of traditional Cretan herbs on upper respiratory tract infections: A pragmatic, prospective observational study. BMC Complement. Altern. Med., 17. · doi:10.1186/s12906-017-1978-7
- Panagiotopoulos, 2021, p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein, Pharmacol. Res.Res. Perspect, 9, e00798, 10.1002/prp2.798 · DOI
- Munos, 2009, Lessons from 60 years of pharmaceutical innovation, Nat. Rev. Drug Discov., 8, 959, 10.1038/nrd2961 · DOI · Paper page
- Firn, 2001, Bioprospecting—Why is it so unrewarding?, Biodiv. Conserv., 12, 207, 10.1023/A:1021928209813 · doi:10.1023/a:1021928209813
- Zhang, 2017, Computational Multitarget Drug Design, J. Chem. Inf. Model., 57, 403, 10.1021/acs.jcim.6b00491 · DOI · Paper page
- Prachayasittikul, 2015, Computer-Aided Drug Design of Bioactive Natural Products, Curr. Top. Med. Chem., 15, 1780, 10.2174/1568026615666150506151101 · doi:10.2174/1568026615666150506151101
- Callaway, 2022, What’s next for AlphaFold and the AI protein-folding revolution, Nature, 604, 234, 10.1038/d41586-022-00997-5 · DOI · Paper page
- Yuriev, 2015, Improvements, trends, and new ideas in molecular docking: 2012–2013 in review, J. Mol. Recognit., 28, 581, 10.1002/jmr.2471 · DOI · Paper page
- Husic, 2018, Markov State Models: From an Art to a Science, J. Am. Chem. Soc., 140, 2386, 10.1021/jacs.7b12191 · DOI · Paper page
- Kuzmanic, 2017, Changes in the free-energy landscape of p38 alpha MAP kinase through its canonical activation and binding events as studied by enhanced molecular dynamics simulations, eLife, 6, e22175, 10.7554/eLife.22175 · DOI
- Daskalakis, 2020, The conformational phase space of the photoprotective switch in the major light harvesting complex II, Chem. Commun., 56, 11215, 10.1039/D0CC04486E · DOI
- Panagiotopoulos, A.A., Karakasiliotis, I., Kotzampasi, D.M., Dimitriou, M., Sourvinos, G., Kampa, M., Pirintsos, S., Castanas, E., and Daskalakis, V. (2021). Natural Polyphenols Inhibit the Dimerization of the SARS-CoV-2 Main Protease: The Case of Fortunellin and Its Structural Analogs. Molecules, 26. · DOI
- Panagiotopoulos, 2020, A simple open source bioinformatic methodology for initial exploration of GPCR ligands’ agonistic/antagonistic properties, Pharmacol. Res.Res. Perspect, 8, e00600, 10.1002/prp2.600 · DOI
- Sonnhammer, 2020, Pathway-specific model estimation for improved pathway annotation by network crosstalk, Sci. Rep., 10, 13585, 10.1038/s41598-020-70239-z · DOI
- Lai, 2020, Editorial: Network Pharmacology and Traditional Medicine, Front. Pharmacol., 11, 1194, 10.3389/fphar.2020.01194 · doi:10.3389/fphar.2020.01194
- Wu, 2018, Network-Based Methods for Prediction of Drug-Target Interactions, Front. Pharmacol., 9, 1134, 10.3389/fphar.2018.01134 · DOI · Paper page
- Muhammad, 2018, Network Pharmacology: Exploring the Resources and Methodologies, Curr. Top. Med. Chem., 18, 949, 10.2174/1568026618666180330141351 · DOI
- Liu, 2020, Computational network biology: Data, models, and applications, Phys. Rep., 846, 1, 10.1016/j.physrep.2019.12.004 · DOI · Paper page
- Kibble, 2015, Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products, Nat. Prod. Rep., 32, 1249, 10.1039/C5NP00005J · DOI · Paper page
- Hopkins, 2008, Network pharmacology: The next paradigm in drug discovery, Nat. Chem. Biol., 4, 682, 10.1038/nchembio.118 · DOI · Paper page
- Guala, 2022, Benefits and Challenges of Pre-clustered Network-Based Pathway Analysis, Front. Genet., 13, 855766, 10.3389/fgene.2022.855766 · DOI
- Gramatica, 2012, QSAR Modeling is not “Push a Button and Find a Correlation”: A Case Study of Toxicity of (Benzo-)triazoles on Algae, Mol. Inform., 31, 817, 10.1002/minf.201200075 · DOI · Paper page
- Gramatica, 2020, Principles of QSAR Modeling: Comments and Suggestions from Personal Experience, Int. J. Quant. Struct.-Prop. Relatsh., 5, 61
- Gramatica, 2007, Principles of QSAR models validation: Internal and external, QSAR Comb. Sci., 26, 694, 10.1002/qsar.200610151 · DOI · Paper page
- Schyman, 2017, vNN Web Server for ADMET Predictions, Front. Pharmacol., 8, 889, 10.3389/fphar.2017.00889 · DOI · Paper page
- Xiong, 2021, ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties, Nucleic Acids Res., 49, W5, 10.1093/nar/gkab255 · DOI · Paper page
- Wei, 2022, Interpretable-ADMET: A web service for ADMET prediction and optimization based on deep neural representation, Bioinformatics, 38, 2863, 10.1093/bioinformatics/btac192 · DOI
- Gupta, 2018, Docking techniques in pharmacology: How much promising?, Comput. Biol. Chem., 76, 210, 10.1016/j.compbiolchem.2018.06.005 · DOI · Paper page
- Murugan, 2022, Artificial intelligence in virtual screening: Models versus experiments, Drug Discov. Today, 27, 1913, 10.1016/j.drudis.2022.05.013 · DOI
- Brown, 2021, A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions, J. Med. Chem., 64, 2312, 10.1021/acs.jmedchem.0c01516 · DOI · Paper page
- Ripphausen, 2010, Quo vadis, virtual screening? A comprehensive survey of prospective applications, J. Med. Chem., 53, 8461, 10.1021/jm101020z · DOI · Paper page
- Kunimoto, 2022, From traditional to data-driven medicinal chemistry: A case study, Drug Discov. Today, 27, 2065, 10.1016/j.drudis.2022.04.017 · DOI
- Wang, 2021, TCM network pharmacology: A new trend towards combining computational, experimental and clinical approaches, Chin. J. Nat. Med., 19, 1
- Singh, 2021, Treasuring the computational approach in medicinal plant research, Prog. Biophys. Mol. Biol., 164, 19, 10.1016/j.pbiomolbio.2021.05.004 · DOI
- Sabe, 2021, Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review, Eur. J. Med. Chem., 224, 113705, 10.1016/j.ejmech.2021.113705 · DOI · Paper page
- Cui, 2013, Chapter Twenty-Five—Case History: Xalkori™ (Crizotinib), a Potent and Selective Dual Inhibitor of Mesenchymal Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) for Cancer Treatment, Ann. Rep. Med. Chem., 48, 421
- Cui, 2020, Discovering Anti-Cancer Drugs via Computational Methods, Front. Pharmacol., 11, 733, 10.3389/fphar.2020.00733 · DOI · Paper page
- Li, R., and Stafford, J. (2009). Structure-Based Design and Characterization of Axitinib. Kinase Inhibitor Drugs, John Wiley & Sons, Inc. · DOI
- Gervasio, F., Spiwok, V., and Mannhold, R. (2019). Biomolecular Simulations in Structure-Based Drug Discovery, Willey. · DOI
- Kampa, 2000, Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines, Nutr. Cancer, 37, 223, 10.1207/S15327914NC372_16 · DOI · Paper page
- Damianaki, 2000, Potent inhibitory action of red wine polyphenols on human breast cancer cells, J. Cell Biochem., 78, 429, 10.1002/1097-4644(20000901)78:3<429::AID-JCB8>3.0.CO;2-M · DOI · Paper page
- Nifli, 2005, Monomeric and oligomeric flavanols are agonists of membrane androgen receptors, Exp. Cell Res., 309, 329, 10.1016/j.yexcr.2005.06.011 · DOI
- Nifli, 2005, Polyphenol interaction with the T47D human breast cancer cell line, J. Dairy Res., 72, 44, 10.1017/S0022029905001172 · doi:10.1017/s0022029905001172
- Kampa, 2011, Novel oligomeric proanthocyanidin derivatives interact with membrane androgen sites and induce regression of hormone-independent prostate cancer, J. Pharmacol. Exp. Ther., 337, 24, 10.1124/jpet.110.177246 · DOI
- Kalyvianaki, 2017, Antagonizing effects of membrane-acting androgens on the eicosanoid receptor OXER1 in prostate cancer, Sci. Rep., 7, 44418, 10.1038/srep44418 · DOI
- Panagiotopoulos, 2022, OXER1 mediates testosterone-induced calcium responses in prostate cancer cells, Mol. Cell Endocrinol., 539, 111487, 10.1016/j.mce.2021.111487 · DOI
- Kampa, 2004, The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line, Exp. Cell Res., 294, 434, 10.1016/j.yexcr.2003.11.027 · DOI
- Panagiotopoulos, 2021, New Antagonists of the Membrane Androgen Receptor OXER1 from the ZINC Natural Product Database, ACS Omega, 6, 29664, 10.1021/acsomega.1c04027 · DOI
- Osakwe, O., and Rizvi, S. (2016). Social Aspects of Drug Discovery, Development and Commercialization, Academic Press.
Cited by
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Applications and potential of in silico approaches for psychedelic chemistry
Karabulut, S., Kaur, H., & Gauld, J. W. (2023) · Molecules · doi:10.3390/molecules28165966 · Cited by 8
Metadata
- Authors
- Pirintsos, S., Panagiotopoulos, A., Bariotakis, M., Daskalakis, V., Lionis, C., Sourvinos, G., Karakasiliotis, I., Kampa, M., & Castanas, E.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2022-06-24
- Volume
- 27
- Issue
- 13
- Pages
- 4060
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W4283585224
- Cited by
- 167
- References
- 13
- FWCI
- 16.34
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Hellenic Foundation for Research and Innovation (H.F.R.I.) (3725, MIS-5000432)
- Greece and the European Union (European Social Fund (ESF) (3725, MIS-5000432)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From Traditional Ethnopharmacology to Modern Natural Drug Discovery: A Methodology Discussion and Specific Examples. https://app.cochat.ai/papers/10.3390/molecules27134060
- The paper
- Pirintsos, S., Panagiotopoulos, A., Bariotakis, M., Daskalakis, V., Lionis, C., Sourvinos, G., Karakasiliotis, I., Kampa, M., & Castanas, E. (2022). From Traditional Ethnopharmacology to Modern Natural Drug Discovery: A Methodology Discussion and Specific Examples. Molecules. https://doi.org/10.3390/molecules27134060
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.